Back
Viridian Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
59
VRDN
Viridian Therapeutics, Inc.
Last Price:
$31.92
Seasonality Move:
-0.64%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VRDN is experiencing selling pressure, which indicates risk of future bearish movement.
Viridian Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 32.38 | Sell |
| 20-day SMA: | 31.89 | Buy |
| 50-day SMA: | 27.68 | Buy |
| 200-day SMA: | 18.94 | Buy |
| 8-day EMA: | 16.87 | Buy |
| 20-day EMA: | 8.27 | Buy |
| 50-day EMA: | 3.61 | Buy |
| 200-day EMA: | 0.94 | Buy |
Viridian Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.99 | Buy |
| Relative Strength Index (14 RSI): | 59.49 | Buy |
| Chaikin Money Flow: | -2556029 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29.94 - 32.64) | Buy |
| Bollinger Bands (100): | (18.07 - 28.67) | Buy |
Viridian Therapeutics, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Viridian Therapeutics, Inc. Stock
Is Viridian Therapeutics, Inc. Stock a Buy?
-
Viridian Therapeutics, Inc. share price is 31.92 while VRDN 8-day simple moving average is 32.38, which is a Sell signal.
-
The stock price of VRDN is 31.92 while Viridian Therapeutics, Inc. 20-day SMA is 31.89, which makes it a Buy.
-
Viridian Therapeutics, Inc. 50-day simple moving average is 27.68 while VRDN share price is 31.92, making it a Buy technically.
-
VRDN stock price is 31.92 and Viridian Therapeutics, Inc. 200-day simple moving average is 18.94, creating a Buy signal.
VRDN Technical Analysis vs Fundamental Analysis
Buy
59
Viridian Therapeutics, Inc. (VRDN)
is a Buy
Is Viridian Therapeutics, Inc. a Buy or a Sell?
-
Viridian Therapeutics, Inc. stock is rated a BuyThe current Viridian Therapeutics, Inc. [VRDN] share price is $31.92. The Score for VRDN is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
Viridian Therapeutics, Inc. Stock Info
Market Cap:
3B
Price in USD:
31.92
Share Volume:
4.8M
Viridian Therapeutics, Inc. 52-Week Range
52-Week High:
34.04
52-Week Low:
9.90
Buy
59
Viridian Therapeutics, Inc. (VRDN)
is a Buy
Viridian Therapeutics, Inc. Share Price Forecast
-
What is the Viridian Therapeutics, Inc. stock price today?The Viridian Therapeutics, Inc. stock price is 31.92 USD today.
-
Will VRDN stock go up or go down?Viridian Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Viridian Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Viridian Therapeutics, Inc. is not overvalued.
Is Viridian Therapeutics, Inc. Stock a Buy?
-
Viridian Therapeutics, Inc. share price is 31.92 while VRDN 8-day exponential moving average is 16.87, which is a Buy signal.
-
The stock price of VRDN is 31.92 while Viridian Therapeutics, Inc. 20-day EMA is 8.27, which makes it a Buy.
-
Viridian Therapeutics, Inc. 50-day exponential moving average is 3.61 while VRDN share price is 31.92, making it a Buy technically.
-
VRDN stock price is 31.92 and Viridian Therapeutics, Inc. 200-day simple moving average is 0.94, creating a Buy signal.
Fundamental Analysis of Viridian Therapeutics, Inc.
Is Viridian Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and an increase next year of $0.02 per share.
Technical Analysis of Viridian Therapeutics, Inc.
Should I short Viridian Therapeutics, Inc. stock?
-
VRDN Moving Average Covergence Divergence (MACD) indicator is 5.99, suggesting Viridian Therapeutics, Inc. is a Buy
-
Viridian Therapeutics, Inc. Relative Strength Index (RSI) is 59.49, which suggest Viridian Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Viridian Therapeutics, Inc. is (29.94 - 32.64), which suggest Viridian Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Viridian Therapeutics, Inc. is (18.07 - 28.67), which suggest Viridian Therapeutics, Inc. is a Buy
* Viridian Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.